摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5,6-dihydro-(R,S)-4-hydroxy-(S)-6-methyl-4H-thieno<2,3-b>thiopyran 7,7-dioxide | 1034290-08-8

中文名称
——
中文别名
——
英文名称
5,6-dihydro-(R,S)-4-hydroxy-(S)-6-methyl-4H-thieno<2,3-b>thiopyran 7,7-dioxide
英文别名
(6S)-6-methyl-7,7-dioxo-5,6-dihydro-4H-thieno[2,3-b]thiopyran-4-ol
5,6-dihydro-(R,S)-4-hydroxy-(S)-6-methyl-4H-thieno<2,3-b>thiopyran 7,7-dioxide化学式
CAS
1034290-08-8
化学式
C8H10O3S2
mdl
——
分子量
218.298
InChiKey
NFUQUGUUAUVBMO-DSEUIKHZSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    433.3±45.0 °C(Predicted)
  • 密度:
    1.462±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.9
  • 重原子数:
    13
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    91
  • 氢给体数:
    1
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    An enantioselective synthesis of the topically-active carbonic anhydrase inhibitor MK-0507: 5,6-dihydro-(S)-4-(ethylamino)-(S)-6-methyl-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide hydrochloride
    摘要:
    The key feature in the synthesis of topically-active carbonic anhydrase inhibitor MK-0507 (13b) is a Ritter reaction that exhibits an unexpected tendency to proceed with retention of chirality. This phenomenon was further studied on model compounds free from potential diastereomeric effects. A mechanism involving transannular stabilization of the sp2-hybridized center by sulfone oxygen is proposed with the net result of double inversion. A second key feature in the preferred sequence to MK-0507 involves the classic problem of how to maximize substitution over elimination. This problem manifests itself in the stereospecific alkylation of 2-mercaptothiophene with derivatized methyl (R)-3-hydroxybutyrate and is compounded by a subsequent Michael reaction leading to a loss of product chirality. Results are presented that eliminate this problem.
    DOI:
    10.1021/jo00059a013
  • 作为产物:
    描述:
    多佐胺-2-2 在 sodium tungstate 、 lithium aluminium tetrahydride 、 双氧水 作用下, 以 四氢呋喃乙酸乙酯甲苯 为溶剂, 反应 2.5h, 生成 5,6-dihydro-(R,S)-4-hydroxy-(S)-6-methyl-4H-thieno<2,3-b>thiopyran 7,7-dioxide
    参考文献:
    名称:
    An enantioselective synthesis of the topically-active carbonic anhydrase inhibitor MK-0507: 5,6-dihydro-(S)-4-(ethylamino)-(S)-6-methyl-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide hydrochloride
    摘要:
    The key feature in the synthesis of topically-active carbonic anhydrase inhibitor MK-0507 (13b) is a Ritter reaction that exhibits an unexpected tendency to proceed with retention of chirality. This phenomenon was further studied on model compounds free from potential diastereomeric effects. A mechanism involving transannular stabilization of the sp2-hybridized center by sulfone oxygen is proposed with the net result of double inversion. A second key feature in the preferred sequence to MK-0507 involves the classic problem of how to maximize substitution over elimination. This problem manifests itself in the stereospecific alkylation of 2-mercaptothiophene with derivatized methyl (R)-3-hydroxybutyrate and is compounded by a subsequent Michael reaction leading to a loss of product chirality. Results are presented that eliminate this problem.
    DOI:
    10.1021/jo00059a013
点击查看最新优质反应信息

文献信息

  • Deoxyfluorination of alcohols with aryl fluorosulfonates
    作者:Xiu Wang、Min Zhou、Qinghe Liu、Chuanfa Ni、Zhongbo Fei、Wei Li、Jinbo Hu
    DOI:10.1039/d1cc02617h
    日期:——
    Aryl fluorosulfonates are developed as a deoxyfluorinating reagent in the transformation of primary and secondary alcohols into the corresponding alkyl fluorides. These reagents feature easy availability, low-cost, high stability and high efficiency. Diverse functionalities including aldehyde, ketone, ester, halogen, nitro, alkene, and alkyne are well tolerated under mild reaction conditions.
    芳基氟磺酸盐被开发用作将伯醇和仲醇转化为相应的烷基氟化物的脱氧氟化试剂。这些试剂具有易得、低成本、高稳定性和高效率的特点。在温和的反应条件下,包括醛、酮、酯、卤素、硝基、烯烃和炔烃在内的多种官能团具有良好的耐受性。
  • J. Org. Chem. 1993,58, 1672-1679
    作者:
    DOI:——
    日期:——
  • US8927740B2
    申请人:——
    公开号:US8927740B2
    公开(公告)日:2015-01-06
  • [EN] TRICYCLIC INHIBITORS OF CARBONIC ANHYDRASE<br/>[FR] INHIBITEURS TRICYCLIQUES D'ANHYDRASE CARBONIQUE
    申请人:PFIZER PROD INC
    公开号:WO2008075148A2
    公开(公告)日:2008-06-26
    [EN] The invention relates to compounds of formula (I) and to pharmaceutically acceptable salts and solvates thereof, wherein R1, R2 and R3 are as defined herein. The invention also relates to methods of treating glaucoma, ocular hypertension, age-related macular degeneration, diabetic macular edema, diabetic retinopathy, hypertensive retinopathy, retinal vasculopathies and intraocular pressure in mammals by administering the compounds of formula (I), and to pharmaceutical compositions which contain the compounds of formula (I) for such treatments. The invention also relates to methods of preparing the compounds of formula (I).
    [FR] L'invention concerne des composés de formule (I) et des sels et solvates pharmaceutiquement acceptables de ceux-ci, R1, R2 et R3 étant tels que définis dans l'invention. L'invention concernent également des procédés de traitement du glaucome, de l'hypertension oculaire, de la dégénérescence maculaire liée au vieillissement, de l'oedème maculaire diabétique, de la rétinopathie diabétique, de la rétinopathie hypertensive, des vasculopathies rétiniennes et de la tension intraoculaire chez des mammifères, par administration des composés de formule (I). L'invention a également pour objet des compositions pharmaceutiques contenant les composés de formule (I), utilisées pour réaliser les traitements sus-mentionnés, ainsi que des procédés de préparation des composés de formule (I).
  • An enantioselective synthesis of the topically-active carbonic anhydrase inhibitor MK-0507: 5,6-dihydro-(S)-4-(ethylamino)-(S)-6-methyl-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide hydrochloride
    作者:Thomas J. Blacklock、Paul Sohar、John W. Butcher、T. Lamanec、E. J. J. Grabowski
    DOI:10.1021/jo00059a013
    日期:1993.3
    The key feature in the synthesis of topically-active carbonic anhydrase inhibitor MK-0507 (13b) is a Ritter reaction that exhibits an unexpected tendency to proceed with retention of chirality. This phenomenon was further studied on model compounds free from potential diastereomeric effects. A mechanism involving transannular stabilization of the sp2-hybridized center by sulfone oxygen is proposed with the net result of double inversion. A second key feature in the preferred sequence to MK-0507 involves the classic problem of how to maximize substitution over elimination. This problem manifests itself in the stereospecific alkylation of 2-mercaptothiophene with derivatized methyl (R)-3-hydroxybutyrate and is compounded by a subsequent Michael reaction leading to a loss of product chirality. Results are presented that eliminate this problem.
查看更多

同类化合物

硫代吡喃鎓,4-甲基-2,6-二苯基-,高氯酸盐 甲基5-乙氧基-3,6-二氢-2H-噻喃-2-羧酸酯 多佐胺-2-4 十四烷酰胺,N-[3-[[4-[[2-[丁基[(4-甲基苯基)磺酰]氨基]苯基]硫代]-4,5-二氢-5-羰基-1-(2,4,6-三氯苯基)-1H-吡唑-3-基]氨基]-4-氯苯基]- 内-3-乙酰基-2-硫杂二环<2.2.2>辛-5-烯 内-3-乙酰基-2-硫杂二环<2.2.1>庚-5-烯 二硫代磷酸O,O-二甲基S-(9-硫杂双环[3.3.1]壬-6-烯-2-基)酯 γ-噻喃 alpha-去甲-3,7-二硫杂雌甾-1,5(10),8,14-四烯-17(E)-醇 N-[(4S,6S)-5,6-二氢-6-甲基-4H-噻吩并[2,3-b]噻喃-4-基]乙酰胺-7,7-二氧化物 8-硫杂双环[3.2.1]辛-2-烯 6-氯-9-硫杂二环[3.3.1]壬-2-烯 5H-异苯并噻喃并[5,6-d][1,3]噻唑 5H-1-苯并噻喃 5-硫代葡萄烯糖 5-氨基-2H-噻喃-3(6H)-酮 5-乙氧基-2H-噻喃-3(6H)-酮 5-乙氧基-2,2,6,6-四甲基-2H-噻喃-3(6H)-酮 5-乙氧基-1,1-二氧代-6H-噻喃-3-酮 5,6-二氢-2H-硫代吡喃-3-羧醛 4-甲氧基-5,6-二氢-2H-噻喃-2-酮 4-溴-3,6-二氢-2H-硫代吡喃 4,8-二甲基-2-硫杂二环(3.3.1)壬-3,7-二烯 3-苄基-2,6-二苯基-2H-噻喃-5-甲醛 3-氧杂-9-硫杂-4-氮杂三环[5.2.2.02,6]十一碳-1,5,7-三烯 3-氧杂-8-硫杂-4-氮杂三环[5.2.2.02,6]十一碳-1(9),2(6),4-三烯 3,6-二氢-2H-噻喃1,1-二氧化 3,6-二氢-2H-噻喃-4-硼酸频哪醇酯 3,6-二氢-2H-噻喃 3,4-二氢-2H-噻喃-5-羧酸1-氧化物 3,4-二氢-2H-噻喃 2H-噻喃-6-甲腈,3,4-二甲基- 2H-噻喃-3(6H)-酮 2-硫杂双环[3.1.0]己-3-烯-6-甲酰肼 2-硫杂-二环[3.1.0]己-3-烯-6-羧酸乙酯 2-甲基-3-硫杂二环[2.2.1]庚-5-烯 2,6-二甲基-4-(2,6-二甲基-4H-硫杂吡喃-4-亚基)-4H-硫杂吡喃 2,6-二氨基-4-苯基-4H-硫代吡喃-3,5-二甲腈 2,4,6-三苯基-2H-噻喃 2'-硫基-2,6,6'-三硫代-2,3,5,5',6,6'-六氢-4H,4'H-3,3'-联噻喃-4,4'-二酮 1-(6-甲基-3,6-二氢-2H-噻喃-2-基)乙酮 (4S,6S)-5,6-二氢-4-羟基-6-甲基噻吩并[2,3-b]噻喃-7,7-二氧化物 (4R,6S)-6-甲基-7,7-二氧化物-5,6-二氢-4H-噻吩并[2,3-b]硫代吡喃-4-基乙酸酯 (2,6-二甲基-噻喃-4-亚基)-丙二腈 ethyl 3-amino-4,6-dicyano-5-phenyl-4H-thiopyran-2-carboxylate 2-aminomethyl-4,5-dipentyl-3,6-dihydro-2H-thiopyran 2-(4-dimethylamino-phenyl)-4,6-diphenyl-thiopyrylium; perchlorate endo-3-Cyano-2-thiabicyclo<2.2.1>hept-5-ene 2,2-dioxide exo-3-Cyano-2-thiabicyclo<2.2.1>hept-5-ene 2,2-dioxide 2-methyl-6-methylsulfanyl-4-furan-2-yl-2H-thiopyran